Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 702843 Administered Subcutaneously to Healthy Volunteers
Clinical trial NCT03165864 · COMPLETED
Trial details
- NCT number
- NCT03165864
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-09
- Primary completion
- 2018-09-25
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.